Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot study

Autoimmun Rev. 2021 Feb;20(2):102726. doi: 10.1016/j.autrev.2020.102726. Epub 2020 Dec 14.
No abstract available

Keywords: Acute respiratory failure; Anakinra; COVID 19; Hyperinflammation; Invasive mechanical ventilation; Ruxolitinib.

Publication types

  • Letter

MeSH terms

  • Aged
  • COVID-19 Drug Treatment*
  • Critical Illness
  • Female
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / therapeutic use*
  • Male
  • Middle Aged
  • Nitriles
  • Pilot Projects
  • Pyrazoles / therapeutic use*
  • Pyrimidines

Substances

  • Interleukin 1 Receptor Antagonist Protein
  • Nitriles
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib